Today: 16 May 2026
Moscow Exchange Last Week: MOEX Gains 2% as Oil Rally Lifts Russian Stocks

Moscow Exchange Last Week: MOEX Gains 2% as Oil Rally Lifts Russian Stocks

MOSCOW, March 7, 2026, 11:17 MSK

The MOEX Russia Index, priced in roubles, climbed roughly 2% to finish at 2,854.11 on Friday, wrapping up the trading week from March 2 to 6. But the RTS, which is calculated in dollars, edged down by about 0.5% for the period, according to market data.

This time, it’s crude that’s pushing things around—not earnings. Brent jumped to $92.69 a barrel by Friday’s close, soaring 27% for the week. That’s the steepest weekly climb since spring 2020. The catalyst: conflict involving Iran that choked off traffic through the Strait of Hormuz, the key Gulf oil corridor. “Every day the Strait stays closed, prices will go higher,” UBS analyst Giovanni Staunovo told Reuters.

This shift resonates outside the trading pits: Moscow Exchange reported that by the end of 2025, close to 41 million individuals held brokerage accounts. The exchange put the total market cap of listed stocks at 52.9 trillion roubles. For February, equity turnover clocked in at 2.4 trillion roubles—daily averages hitting 91.4 billion roubles.

Russian exporters saw prices move sharply higher. According to Reuters, Urals crude loading out of Primorsk jumped to $68.6 a barrel, well above last week’s $45.7. Igor Yushkov at the government-run Financial University said the Hormuz situation was setting up “favourable conditions” for Russia’s energy revenues. Reuters

Energy and shipping stocks took the lead by Friday’s close, with Sovcomflot up 7.8%, Rosneft gaining 4.9%, Lukoil climbing 3.9%, and Novatek advancing 3.3%, according to Interfax. The agency also noted the Central Bank fixed the official dollar rate for March 7 at 79.15 roubles—a jump of 1.88 roubles over the week. That uptick in the dollar partly accounts for why the RTS underperformed the rouble-based benchmark.

Commodity buying spilled over to fertilizer stocks as well. Fertilizer makers Acron and PhosAgro jumped 3% and 4% on MOEX since Feb. 28, according to Reuters, with traders factoring in the risk of tighter global supply after shutdowns in the Middle East and shipping snags in Hormuz.

The exchange rolled out index tweaks with real implications for some stocks. MOEX announced that Lenta’s ordinary shares are set to be added to the MOEX Russia and RTS indices beginning March 20. PIK’s ordinary shares, on the other hand, are being weighed for removal. That kind of move can push funds and investors, especially those tracking the benchmarks, to adjust their holdings.

The oil-fueled rally this week still looks shaky. Reuters said Novorossiysk—one of the Black Sea’s main oil ports—only restarted shipments on Friday after drone attacks forced a halt earlier in the week. Meanwhile, Moscow’s city government announced its first investment spending cut since the pandemic, highlighting mounting economic strain. If shipping is hit again or oil prices slip, key support for the market could vanish.

Local strategists aren’t calling a top yet. Bogdan Zvarich, who leads banking and financial-market analysis at PSB, keeps the focus on that 2,800-2,900 band for now. He points to oil and gas, base metals, and fertilizer names as the sectors catching his eye in the near term.

Oil is front and center next week. Goldman Sachs warned Friday that crude could push past $100 a barrel if Hormuz supply issues drag on—potentially a tailwind for Moscow shares, but it leaves room for a sudden pullback too.

Stock Market Today

  • PVH Shares Drop 3% as April Inflation Surges to 3.8% Annual Rate
    May 15, 2026, 8:16 PM EDT. PVH shares fell 3% following the latest Consumer Price Index report showing inflation at a 3.8% annual rate in April, the fastest since 2023. Energy costs, notably a 5.4% rise in gasoline prices linked to the Iran conflict, sharply increased. Higher prices for essentials like food and shelter raised concerns over reduced consumer spending on discretionary items, impacting retail and consumer goods sectors. PVH's stock, volatile with 14 moves over 5% in the past year, reacted moderately compared to a recent 7.7% drop amid crude oil price surges and weak consumer sentiment. Goldman Sachs lowered its 2026 discretionary cash flow forecast from 5.1% to 3.7%, citing squeezed consumer budgets. PVH trades 18% below its 52-week high, with long-term investors facing a decline in value.

Latest articles

Accuray inks 10-year cancer tech agreement, shares in focus

Accuray inks 10-year cancer tech agreement, shares in focus

16 May 2026
Accuray and the University of Wisconsin School of Medicine and Public Health signed a 10-year research agreement focused on Accuray’s Stellar adaptive radiotherapy platform. The announcement came after market close, with Accuray shares ending down 5.2% at $0.27. The deal follows Accuray’s recent withdrawal of fiscal 2026 guidance and ongoing financial pressures.
Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

16 May 2026
Origin Materials asked shareholders to approve a plan to liquidate and dissolve the company, estimating an initial payout of $0.61 to $3.54 per share depending on asset sales and claims. Shares rose 15% to $1.43 after the filing. The company reported a 91% drop in first-quarter revenue and warned it may not survive without the wind-down. Origin cut 59% of its workforce and CEO John Bissell stepped down May 1.
NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
HCW Biologics jumps 262% after Trimmune deal, Q1 profit, Nasdaq risk update

HCW Biologics jumps 262% after Trimmune deal, Q1 profit, Nasdaq risk update

16 May 2026
HCW Biologics shares jumped 262% to $1.22 Friday after the company posted a $3.47 million first-quarter profit, driven by a $6.5 million licensing deal with Beijing Trimmune Biotech. The company faces a possible Nasdaq delisting and will ask shareholders to approve a reverse stock split on June 15. HCW plans to report early Phase 1 data for its alopecia drug in the first half of 2026.
Netskope Inc rolls out AI Guardrails ahead of March 11 earnings as enterprise AI security race heats up
Previous Story

Netskope Inc rolls out AI Guardrails ahead of March 11 earnings as enterprise AI security race heats up

Microsoft Stock Price Week Ahead: Can MSFT Hold Near $409 as AI Demand Faces a CPI Test?
Next Story

Microsoft Stock Price Week Ahead: Can MSFT Hold Near $409 as AI Demand Faces a CPI Test?

Go toTop